Pseudomonas vaccine - CJ Corporation

Drug Profile

Pseudomonas vaccine - CJ Corporation

Alternative Names: CFC-101

Latest Information Update: 07 Dec 2006

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator CJ Corporation
  • Class Bacterial vaccines; Pseudomonas vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Pseudomonal infections

Most Recent Events

  • 19 Aug 2003 Phase-III clinical trials in Pseudomonal infections in South Korea (IM)
  • 23 Dec 2002 Cheil Jedang is now called CJ Corporation
  • 14 Jun 2000 Phase-II clinical trials for Pseudomonal infections in South Korea (IM)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top